Curoverse
Curoverse48Curoverse
Provides genomic and biomedical computing solutions for managing and analyzing large datasets.
About
What does Curoverse do?
Curoverse provides genomic and biomedical computing solutions that enable organizations to manage, process, analyze, and share massive biomedical datasets. Their core product, Arvados, is an open-source computing system designed for handling petabytes of data, serving bioinformaticians, researchers, IT teams, and clinical testing labs. Arvados offers flexible deployment options on-premise or in the cloud, ensuring data and software remain under user control for secure collaboration.
What is Curoverse's revenue?
StartupHub estimates Curoverse's annual revenue at $283K (range $128K to $529K, 29% confidence), based on comparable companies in the sector.
What is Curoverse's valuation?
StartupHub estimates Curoverse's effective valuation at $12.7M (range $8.0M to $19.2M, 10% confidence), based on comparable companies in the sector.
How much funding has Curoverse raised?
Curoverse has raised a total of $3M in funding. The most recent round on record is Later Stage VC.
Where is Curoverse headquartered?
Curoverse is headquartered in Boston, United States.
When was Curoverse founded?
Curoverse was founded in 2010.
What industry does Curoverse operate in?
Curoverse operates in Genomics, Biotech, HealthTech, Data Management, Bioinformatics, Open Source.
What is Curoverse's current status?
Curoverse's current operating status is: Inactive.
“Curoverse Gets $1.5M to Develop Open Source Genomics Tool.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.